ZOMETA Significantly Increased Bone Mineral Density in Men Receiving Hormonal Therapy for Non-Metastatic Prostate Cancer, Study Showed

[Guest guest]

This article was sent to you by , courtesy of Cancersource.com:

To: supporters (prostatecancersupport )

From: (patricia@...)

Comment: Good evidence for those who are having difficulty getting it from

their consultant.

Article Title: ZOMETA Significantly Increased Bone Mineral Density in Men

Receiving Hormonal Therapy for Non-Metastatic Prostate Cancer, Study Showed

Treatment with ZOMETA (zoledronic acid) Injection significantly increased

bone-mineral density (BMD) in the spines and hips of men receiving hormonal

therapy for prostate cancer, according to a study published in this month’s

Journal of Urology.

If you're interested in reading this article, point your web browser to:

http://www.cancersourcern.com/news/detail.cfm?DiseaseID=5 & ContentID=27174

(If necessary, you can copy and paste the URL above into the location line of

your browser.)

This free message was sent to you by . If you have questions or

comments about this service, please e-mail info@....